Grifols Makes a Variety of Postexposure Prophylaxis and Immune Globulin Products for Your Patients
Since 1940, Grifols has been serving the medical community by providing innovative therapies and manufacturing high-quality postexposure prophylaxis. Grifols has been a global provider of plasma-derived therapies since the company's founding. Grifols is uniquely positioned to deliver the treatments patients need, when they need them. Trust Grifols with your immune globulin product needs.
Hypermunes Include Specific Immunoglobulins That Provide Rapid Immune Coverage in Potentially Life-Threatening Situations1
Active vs Passive Immunity
Active immunity: As seen in vaccines, active immunity stimulates the immune system to produce antigen-specific humoral (antibody) and cellular immunity. This immunity can be lifelong, but it may take weeks to build efficacy. In times of urgency, when the need is acute, passive immunity is required.1
Passive immunity is the transfer of antibodies produced by human donors to another individual. This protection is temporary. Passive immunity, provided by the Hypermunes product line, gives you the immediate protection that is needed when faced with potentially life-threatening situations.1
Watch This Video to Learn More
A vaccine alone may not be enough for your patients faced with critical situations. Make sure you're prepared.
Vaccines can take weeks to build efficacy but can protect for years. Immune globulins such as Hypermunes provide immediate protection, which allows the vaccine the time needed to establish active immunity in high-risk situations. While Hypermunes are often given with a vaccine, they are sometimes given on their own.1
Hypermunes contain high titers of antibodies for postexposure prophylaxis, providing rapid immune protection.2